XML 64 R44.htm IDEA: XBRL DOCUMENT v3.25.1
FINANCIAL INSTRUMENTS AND RISK MANAGEMENT
12 Months Ended
Dec. 31, 2024
FINANCIAL INSTRUMENTS AND RISK MANAGEMENT  
FINANCIAL INSTRUMENTS AND RISK MANAGEMENT

NOTE 38 - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT

38.1- Capital risk management

The Company monitors capital based on the financial leverage ratio. This index corresponds to the net debt divided by the total capital. Financial leverage, in turn, corresponds to the total of loans, financing and short-and long-term debentures (see note 22), subtracted from the amount of cash and cash equivalents and securities - TVM (without considering restricted cash): see notes 6 and 8. Total capital is determined by adding net equity, as demonstrated in the consolidated balance sheet, to the net debt.

12/31/2023

 

    

12/31/2024

    

Reclassified

Total loans, financing and debentures

 

75,620,574

 

59,460,369

(+) Derivative financial instruments - debt protection

 

(974,381)

 

657,514

(-) Marketable securities

 

(9,385,179)

 

(6,352,895)

(-) Cash and cash equivalents

 

(26,572,522)

 

(13,046,371)

Net debt

 

38,688,492

 

40,718,617

(+) Total shareholders’ equity

 

121,999,776

 

112,464,644

Total capital

160,688,268

153,183,261

Financial leverage index

24

27

38.2 - Classification of financial instruments by category

The carrying amounts of financial assets and liabilities represent a reasonable approximation of fair value. The Company uses the following classification for its financial instruments and their respective levels of fair value:

12/31/2023

    

Level

    

12/31/2024

    

Reclassified

FINANCIAL ASSETS

 

  

 

  

 

  

Amortized cost

 

 

39,017,827

 

24,673,081

Cash and cash equivalents

26,572,522

13,046,371

Accounts receivable, net

 

 

6,513,888

 

5,859,928

Restricted cash

3,679,483

2,772,947

Reimbursement rights

 

 

1,613,335

 

2,365,685

Loans, financing and debentures

 

 

638,599

 

628,150

Fair value through result

 

 

11,537,109

 

6,726,501

Financial investments

 

2

 

8,967,937

 

5,925,693

Beneficiary parties

2

417,242

427,202

Derivative financial instruments

 

2

 

2,151,930

 

373,606

Fair value through other comprehensive income

 

946,059

1,104,381

Investments (Interests)

1

 

861,234

1,104,381

Derivative financial instruments

2

84,825

FINANCIAL LIABILITIES

  

 

  

 

  

Amortized cost

 

109,460,695

 

100,988,575

Loans, financing and debentures

 

59,297,533

 

54,299,620

Obligations of Law No. 14,182/2021

42,022,123

39,519,406

Suppliers

 

2,764,288

 

2,963,867

Compulsory loan – Agreements

 

1,105,534

 

896,746

RGR Returns

932,250

1,319,921

Reimbursement obligations

70,803

Shareholders compensation

 

2,490,668

 

1,154,836

Leases

 

182,583

 

216,747

Concessions payable - use of public property

594,913

617,432

Fair value through result

 

 

17,500,976

 

7,138,184

Loans, financing and debentures

2

16,323,041

6,480,670

Derivative financial instruments

 

2

 

1,177,935

 

657,514

The financial assets and liabilities recorded at fair value are classified and disclosed in accordance with the following levels:

Level 1 - quoted prices (not adjusted) in active, liquid and visible markets for identical assets and liabilities that are accessible on the measurement date;

Level 2 - quoted prices (which may or may not be adjusted) for similar assets or liabilities in active markets, other unobservable inputs at level 1, directly or indirectly, under the terms of the asset or liability; and

Level 3 - assets and liabilities whose prices do not exist or where these prices or valuation techniques are supported by a small or non-existent, unobservable or liquid market. At this level, the estimate of fair value becomes highly subjective.

38.3 - Financial risk management

In carrying out its activities, the Company is impacted by risk events that may compromise its strategic objectives. Risk management has aims to anticipate and minimize the adverse effects of such events on the Company’s business and economic-financial results.

For the management of financial risks, the Company has defined operational and financial policies and strategies, approved by internal committees and by management, which aim to provide liquidity, security and profitability to its assets and maintain the levels of indebtedness and debt profile defined for the flows economic-financial aspects.

The sensitivity analyzes below were prepared with the objective of measuring the impact of changes in market variables on each of the Company’s financial instruments. These are, therefore, projections based on assessments of macroeconomic scenarios, which does not mean that the transactions will have the values presented in the analysis period considered.

The main financial risks identified in the risk management process are:

38.3.1 - Interest rate risk

a)National indexes

Interest rate appreciation risk

Effect on result

Balance on

Scenario I -

Scenario II

Scenario III 

    

12/31/2024

    

Probable 20251

    

(+25%)1

    

(+50%)1

CDI

Loans, financing and debentures

(44,428,113)

(6,619,789)

(8,276,957)

(9,929,683)

Financing and loans receivable

450,000

67,050

83,835

100,575

Impact on the result

(43,978,113)

(6,552,739)

(8,193,122)

(9,829,108)

SELIC

Loans, financing and debentures

(114,955)

(17,243)

(21,554)

(25,865)

AIC Reimbursement

112,816

16,922

21,153

25,384

Impact on the result

(2,139)

(321)

(401)

(481)

TJLP

Loans, financing and debentures

(2,873,003)

(251,100)

(314,019)

(376,651)

Impact on the result

(2,873,003)

(251,100)

(314,019)

(376,651)

IGPM (General Market Price Index)

Leases

(182,583)

(8,618)

(10,772)

(12,927)

Impact on the result

(182,583)

(8,618)

(10,772)

(12,927)

Obligations of Law No. 14,182/2021

(42,022,123)

(2,252,386)

(2,815,482)

(3,378,579)

IPCA

Loans, financing and debentures

(26,215,920)

(1,405,173)

(1,756,467)

(2,107,760)

Right of reimbursement

1,500,519

80,428

100,535

120,642

Financing and loans receivable

502,585

26,939

33,673

40,408

Impact on the result

(66,234,939)

(3,550,192)

(4,437,741)

(5,325,289)

Impact on profit or loss in case of assessment of national indexes

(10,362,970)

(12,956,055)

(15,544,456)

(1) Assumptions adopted:

12/31/2024

Likely

+25%

+50%

CDI

12.15

14.90

18.63

22.35

SELIC

12.25

15.00

18.75

22.50

TJLP

7.43

8.74

10.93

13.11

IGPM (General Market Price Index)

6.54

4.72

5.90

7.08

IPCA

4.89

5.36

6.70

8.04

38.3.2 - Liquidity risk

The table below analyzes, in nominal values, the non-derivative financial liabilities of the Company, by maturity range, for the period remaining on the balance sheet until the final contractual date. Contractual maturity is based on the most recent date the Company must settle obligations and includes the corresponding related contract interest, if any.

12/31/2024

Nominal payment flow

Up to 1 year

    

From 1 to 2 Years

    

From 2 to 5 Years

    

Over 5 Years

    

Total

FINANCIAL LIABILITIES (Current / Non-Current)

 

22,599,741

 

22,968,512

 

41,394,062

 

97,366,345

 

184,328,660

Obligations of Law No. 14,182/2021

2,953,184

3,439,353

12,906,745

62,908,147

82,207,429

Loans, financing and debentures

 

13,769,529

 

18,913,993

 

28,317,110

 

34,133,371

 

95,134,002

Suppliers

2,756,329

7,959

2,764,288

RGR Returns

 

492,276

 

439,974

 

 

 

932,250

Reimbursement Obligations

55,517

15,286

70,803

Shareholders remuneration

2,490,668

2,490,668

Leases

 

31,192

 

20,183

 

29,536

 

41,971

 

122,882

Concessions payable UBP

 

51,046

 

131,764

 

140,671

 

282,856

 

606,337

12/31/2023

Nominal payment flow

    

Up to 1 year

    

From 1 to 2 Years

    

From 2 to 5 Years

    

Over 5 Years

    

Total

FINANCIAL LIABILITIES (Current / Non-Current)

 

23,534,123

 

16,402,453

 

37,162,840

 

86,456,689

 

163,556,105

Obligations of Law No. 14,182/2021

 

2,196,092

 

2,832,052

 

11,675,962

 

64,112,911

 

80,817,017

Loans, financing and debentures

16,303,004

12,806,056

24,871,962

21,856,170

75,837,192

Suppliers

 

2,963,867

 

 

 

 

2,963,867

RGR Returns

439,974

439,974

439,974

1,319,922

Reimbursement Obligations

8,572

8,572

Shareholders remuneration

1,522,866

1,522,866

Leases

 

48,482

 

75,682

 

49,138

 

66,936

 

240,238

Concessions payable UBP

 

51,266

 

248,689

 

125,804

 

420,672

 

846,431

38.3.3 - Derivative financial instruments

38.3.3.1. Derivative financial instruments for debt protection and firm commitments

    

12/31/2024

    

12/31/2023

    

12/31/2024

    

12/31/2023

Maturity

    

Notional value

    

Assets

Liability

Debt protection derivative

 

  

 

  

Swap - US$ vs CDI

 

1/8/2025

493,000

118,733

 

Swap - US$ vs CDI

 

2/4/2025

2,535,300

500,998

 

220,165

Swap - US$ vs CDI

 

8/29/2025

219,150

54,290

 

8,611

Swap - US$ vs CDI

 

12/9/2025

500,000

13,170

 

Swap - EUR vs CDI

12/23/2025

500,000

5,245

Swap - US$ vs CDI

6/20/2029

232,873

47,415

7,603

3,601

Swap - US$ vs CDI

2/4/2030

3,782,873

715,544

235,194

425,137

Swap - IPCA vs CDI

9/15/2034

1,630,000

89,867

Swap - US$ vs CDI

12/4/2034

2,378,400

266,397

185,005

Swap - US$ vs CDI

1/11/2035

4,229,025

287,736

316,342

Swap - IPCA vs CDI

6/15/2031

4,900,000

142,788

343,924

2,152,316

1,177,935

657,514

Long-term commitment derivatives

NDF US$

4/30/2025

67,113

224

NDF US$ and primary aluminum

12/2/2025

1,342

274

NDF US$ and primary aluminum

8/3/2026

156,583

30,129

NDF US$ and primary aluminum

9/1/2026

60,175

11,780

NDF US$ and primary aluminum

9/2/2026

210,668

42,032

84,439

2,236,755

1,177,935

657,514

    

    

12/31/2024

    

12/31/2023

Variation of fair value of the derivative

Swap - US$ vs CDI

 

1/8/2025

 

109,356

 

Swap - US$ vs CDI

 

4/2/2025

 

560,392

 

(275,755)

Swap - US$ vs CDI

 

8/29/2025

 

52,930

 

(8,610)

Swap - US$ vs CDI

 

12/9/2025

 

13,170

 

Swap - EUR vs CDI

12/23/2025

5,245

Swap - US$ vs CDI

18/06/2026

68,485

Swap - US$ vs CDI

6/20/2029

41,141

(6,373)

Swap - US$ vs CDI

2/4/2030

634,410

(512,050)

Swap - IPCA vs CDI

6/15/2031

(296,800)

Swap - IPCA vs CDI

9/15/2034

(89,867)

Swap - US$ vs CDI

12/4/2034

81,392

Swap - US$ vs CDI

1/11/2035

(28,606)

Variation of fair value of the protected debt

 

 

 

Bonds

2/4/2025

(765,876)

49,395

Bonds

 

2/4/2030

 

(1,068,243)

 

(129,796)

Bonds

 

1/11/2035

 

(95,074)

 

Credit agreement

 

1/8/2025

 

(165,382)

 

Credit agreement

 

8/29/2025

 

(68,059)

 

(15,503)

Credit agreement

 

12/9/2025

 

(17,497)

 

Credit agreement

6/18/2026

(257,569)

CGT ESUL EURO

12/23/2025

(7,838)

KFW

6/20/2029

(59,203)

(9,689)

Debentures

6/15/2031

(53,596)

Debentures

9/15/2034

46,824

SPA (SACE)

12/4/2034

(206,217)

Net financial result

 

 

(1,566,482)

 

(908,381)

Earnings/(loss) recognized in the result

    

2024

    

2023

Balance on January 1

(6,757,343)

Designation of protected debt

 

(18,630,425)

 

(6,802,523)

Fair value assessment - result

 

(2,717,730)

 

(105,593)

Amortizations

 

4,847,986

 

150,773

Balance as of December 31st

 

(23,257,512)

 

(6,757,343)

Derivatives Changes – Hedge

    

2024

    

2023

Balance on January 1

(283,908)

986,862

Fair value assessment - result

 

1,151,248

 

(1,416,044)

Fair value assessment - OCI

 

84,825

 

Amortizations

 

106,655

 

145,274

Balance as of December 31st

 

1,058,820

 

(283,908)

Assets

 

2,236,755

 

373,606

Liabilities

 

1,177,935

 

657,514

Accounting Policy

Recognition and measurement:

Financial assets and liabilities are initially recognized at fair value and subsequently measured at amortized cost or fair value, following the rules of IFRS 9.

Transaction costs directly attributable to the acquisition or issuance of financial assets and liabilities are added to or deducted from the fair value of the financial assets or liabilities, if applicable, after initial recognition.

Financial assets

The Company’s financial assets are initially recognized at fair value and subsequently measured in their entirety at amortized cost or fair value, depending on the classification of the financial assets.

a) A financial asset is measured at amortized cost if it meets both of the following conditions:

It is held within a business model whose objective is to hold financial assets to receive contractual cash flows; and
Its contractual terms generate, on specific dates, cash flows that are related only to the payment of principal and interest on the outstanding principal amount.

b) A financial asset is measured at Fair Value through Other Comprehensive Income – FVOCI if it meets both of the following conditions:

It is maintained within a business model whose objective is achieved both by the receipt of contractual cash flows and by the sale of financial assets; and
Its contractual terms generate, on specific dates, cash flows that are related only to the payment of principal and interest on the outstanding principal amount.

Upon initial recognition of an investment in an equity instrument that is not held for trading, the Company may irrevocably choose to present subsequent changes in the fair value of the investment in Other Comprehensive Income (OCI). The Company chooses to record the change in the fair value of its equity instruments, when it does not have control, shared control and significant influence, in Other Comprehensive Income (OCI).

c) Financial assets not classified as measured at amortized cost or FVOCI, as described above, are classified as measured at fair value through profit or loss. On initial recognition, the Company may irrevocably designate a financial asset that otherwise meets the requirements to be measured at amortized cost or FVOCI as FVOCI if doing so eliminates or significantly reduces an accounting mismatch that would otherwise arise.

Business model assessment:

The Company carries out an assessment of the objective of the business model in which a financial asset is kept in the portfolio because it better reflects the way in which the business is managed and the information is provided to Management.

Valuation on contractual cash flows:

For the purposes of assessing whether the contractual cash flows are only payment of principal and interest, the principal is defined as the fair value of the financial asset upon initial recognition. The interest is defined as a consideration for the time value of money and for the credit risk associated with the principal outstanding over a given period of time and for the other basic risks and costs of borrowing.

The Company considers the contractual terms of the instrument to assess whether the contractual cash flows are composed only of payments of principal and interest. This includes assessing whether the financial asset contains a contractual term that could change the timing or the value of contractual cash flows so that it would not meet this condition.

Financial liabilities:

Financial liabilities, which include loans and financing, suppliers and other accounts payable, are initially measured at fair value and subsequently at amortized cost using the effective interest method. Interest expenses, foreign exchange gains and losses are recognized in the income statement.

The effective interest method is used to calculate the amortized cost of a financial liability and to allocate its interest expense over the relevant period. The effective interest rate is the rate that accurately discounts the estimated future cash flows (including fees and premiums paid or received that constitute an integral part of the effective interest rate, transaction costs and other premiums or discounts) over the estimated life of the financial liability or, where appropriate, a shorter period, to the initial recognition of the net carrying amount.

Derivative financial instruments:

The Company has derivative financial instruments to reduce its exposure to interest rate and exchange rate risks, including interest rate swap contracts and NDF (Non-Deliverable Forward).

Derivatives are initially recognized at fair value on the date of contracting and subsequently measured by the change in fair value. Changes in the fair values of derivatives that serve as instruments for fair value hedging are recognized in the financial result, while derivatives related to cash flow hedging are recognized in other comprehensive income (OCI).

Hedge accounting:

The Company, considering the benefits of reducing the volatility of results and the transparency of the effects of the protection, adopts hedge accounting. As provided in IFRS 9 - Financial Instruments, there are three types of hedging relationships:

Fair value hedge: the hedge of exposure to changes in the fair value of a recognized asset or liability or an unrecognized firm commitment;
Cash flow hedge: the hedge of exposure to variability in cash flows that is attributable to a specific risk associated with the entire recognized asset or liability, or a component thereof, or a highly probable forecast transaction that could affect the result; and
Net investment hedge in foreign operations: the protection of a net investment in a foreign operating unit.

The Company’s debts, hedged items, are designated for fair value hedging, and changes in the fair values of the instruments and hedged items are recognized in profit or loss.

Unrecognized firm commitments, hedged objects, are designated for cash flow hedging, whose changes in the fair values of the hedging instruments are recognized in other comprehensive income – OCI.

Estimates and critical judgments

For hedged assets traded in an active market, fair value measurement is performed based on observable market prices, using a specialized tool, such as Bloomberg. In other cases, hedged instruments and assets are measured using the valuation techniques mentioned in IFRS 13 – Fair Value Measurement, which generally use assumptions based on market conditions.